| Citation: |
YU Pan, YAO Jialiang, TIAN Jianhui. Chronic Stress Promotes Tumor Progression and Metastasis: From Mechanisms to Therapeutic Strategies[J]. Cancer Research on Prevention and Treatment, 2025, 52(4): 324-330. DOI: 10.3971/j.issn.1000-8578.2025.24.1078
|
Metastasis is a key cause of death in tumor patients, and a number of tumor patients have comorbid psychosomatic abnormalities and are in a state of chronic stress. Chronic stress affects the release of many kinds of hormones and neurotransmitters, such as epinephrine, norepinephrine, dopamine, glucocorticoids, cortisol, sex hormones, etc., through the hypothalamus–pituitary–adrenal axis and sympathetic nervous system. These substances can act on the β-adrenergic receptor, glucocorticoid receptor, etc., on tumor cells, immune cells, and other cells in the tumor microenvironment and promote the tumor progression and metastasis by directly enhancing the invasive and metastatic ability of tumor cells, inducing the formation of the immunosuppressive microenvironment and promoting tumor angiogenesis and other pathways. Antipsychotic drugs, β-blockers, and glucocorticoid receptor antagonists have inhibitory effects on chronic stress-mediated tumor metastasis and have achieved certain clinical efficacy. Relevant studies have been carried out on traditional Chinese medicine decoctions and monomers, which can inhibit tumor metastasis by modulating the immune microenvironment and reversing chronic stress-mediated hormonal changes. The psychological problems of tumor patients have gradually received attention, and the development of new anti-metastatic drugs based on the mechanism of action of chronic stress in promoting tumor progression and metastasis provides new ideas for the improvement of the overall efficiency of tumor prevention and treatment.
Competing interests: The authors declare that they have no competing interests.
| [1] |
Wang YH, Li JQ, Shi JF, et al. Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies[J]. Mol Psychiatry, 2020, 25(7): 1487-1499. doi: 10.1038/s41380-019-0595-x
|
| [2] |
Moore JX, Andrzejak SE, Bevel MS, et al. Exploring racial disparities on the association between allostatic load and cancer mortality: A retrospective cohort analysis of NHANES, 1988 through 2019[J]. SSM Popul Health, 2022, 19: 101185. doi: 10.1016/j.ssmph.2022.101185
|
| [3] |
Fraterman I, Reijers ILM, Dimitriadis P, et al. Association between pretreatment emotional distress and neoadjuvant immune checkpoint blockade response in melanoma[J]. Nat Med, 2023, 29(12): 3090-3099. doi: 10.1038/s41591-023-02631-x
|
| [4] |
Yan J, Chen Y, Luo M, et al. Chronic stress in solid tumor development: from mechanisms to interventions[J]. J Biomed Sci, 2023, 30(1): 8. doi: 10.1186/s12929-023-00903-9
|
| [5] |
de Kloet ER, Joëls M. The cortisol switch between vulnerability and resilience[J]. Mol Psychiatry, 2024, 29(1): 20-34. doi: 10.1038/s41380-022-01934-8
|
| [6] |
Wang C, Shen Y, Ni J, et al. Effect of chronic stress on tumorigenesis and development[J]. Cell Mol Life Sci, 2022, 79(9): 485. doi: 10.1007/s00018-022-04455-3
|
| [7] |
Noushad S, Ahmed S, Ansari B, et al. Physiological biomarkers of chronic stress: A systematic review[J]. Int J Health Sci(Qassim), 2021, 15(5): 46-59.
|
| [8] |
Cui B, Peng F, Lu J, et al. Cancer and stress: NextGen strategies[J]. Brain Behav Immun, 2021, 93: 368-383. doi: 10.1016/j.bbi.2020.11.005
|
| [9] |
Liu Y, Tian S, Ning B, et al. Stress and cancer: The mechanisms of immune dysregulation and management[J]. Front Immunol, 2022, 13: 1032294. doi: 10.3389/fimmu.2022.1032294
|
| [10] |
Zhang M, Yue X, Xu S, et al. Dipeptidyl peptidase-4 disturbs adipocyte differentiation via the negative regulation of the glucagon-like peptide-1/adiponectin-cathepsin K axis in mice under chronic stress conditions[J]. FASEB J, 2024, 38(10): e23684. doi: 10.1096/fj.202400158R
|
| [11] |
Bernabé DG. Catecholamines Mediate Psychologic Stress-Induced Cancer Progression[J]. Cancer Res, 2021, 81(20): 5144-5146. doi: 10.1158/0008-5472.CAN-21-3077
|
| [12] |
Sousa DM, Fernandes V, Lourenço C, et al. Profiling the Adrenergic System in Breast Cancer and the Development of Metastasis[J]. Cancers(Basel), 2022, 14(22): 5518.
|
| [13] |
Pan C, Wu J, Zheng S, et al. Depression accelerates gastric cancer invasion and metastasis by inducing a neuroendocrine phenotype via the catecholamine/β(2) -AR/MACC1 axis[J]. Cancer Commun(Lond), 2021, 41(10): 1049-1070.
|
| [14] |
Allen JK, Armaiz-Pena GN, Nagaraja AS, et al. Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction[J]. Cancer Res, 2018, 78(12): 3233-3242. doi: 10.1158/0008-5472.CAN-16-1701
|
| [15] |
Zhou Y, Chu P, Wang Y, et al. Epinephrine promotes breast cancer metastasis through a ubiquitin-specific peptidase 22-mediated lipolysis circuit[J]. Sci Adv, 2024, 10(33): eado1533. doi: 10.1126/sciadv.ado1533
|
| [16] |
Qi YH, Yang LZ, Zhou L, et al. Sympathetic nerve infiltration promotes stomach adenocarcinoma progression via norepinephrine/β2-adrenoceptor/YKL-40 signaling pathway[J]. Heliyon, 2022, 8(12): e12468. doi: 10.1016/j.heliyon.2022.e12468
|
| [17] |
Qiu J, Shen Z, Jiang G, et al. Isoproterenol-induced Upregulation of HPSE Accelerates Triple-negative Breast Cancer Cell Proliferation and Migration through Enhancing the Transcriptional Activity of HIF-1α[J]. Anticancer Agents Med Chem, 2023, 23(4): 470-477. doi: 10.2174/1871520622666220817125817
|
| [18] |
Yong L, Yao Y, Chen GS, et al. QAP14 suppresses breast cancer stemness and metastasis via activation of dopamine D1 receptor[J]. Acta Pharmacol Sin, 2022, 43(4): 1001-1012. doi: 10.1038/s41401-021-00701-9
|
| [19] |
Jiao Y, Kang G, Pan P, et al. Acetylcholine promotes chronic stress-induced lung adenocarcinoma progression via α5-nAChR/FHIT pathway[J]. Cell Mol Life Sci, 2023, 80(5): 119. doi: 10.1007/s00018-023-04742-7
|
| [20] |
Buonaiuto R, Neola G, Cecere SC, et al. Glucocorticoid Receptor and Ovarian Cancer: From Biology to Therapeutic Intervention[J]. Biomolecules, 2023, 13(4): 653. doi: 10.3390/biom13040653
|
| [21] |
Feldman RD, Ding Q, Hussain Y, et al. Aldosterone mediates metastatic spread of renal cancer via the G protein-coupled estrogen receptor (GPER)[J]. FASEB J, 2016, 30(6): 2086-2096. doi: 10.1096/fj.15-275552
|
| [22] |
Nair S, Sachdeva G. Estrogen matters in metastasis[J]. Steroids, 2018, 138: 108-116. doi: 10.1016/j.steroids.2018.07.006
|
| [23] |
Zhang L, Pan J, Chen W, et al. Chronic stress-induced immune dysregulation in cancer: implications for initiation, progression, metastasis, and treatment[J]. Am J Cancer Res, 2020, 10(5): 1294-1307.
|
| [24] |
Qiao G, Chen M, Mohammadpour H, et al. Chronic Adrenergic Stress Contributes to Metabolic Dysfunction and an Exhausted Phenotype in T Cells in the Tumor Microenvironment[J]. Cancer Immunol Res, 2021, 9(6): 651-664. doi: 10.1158/2326-6066.CIR-20-0445
|
| [25] |
Zhao X, Li F, Cheng C, et al. Social isolation promotes tumor immune evasion via β2-adrenergic receptor[J]. Brain Behav Immun, 2025, 123: 607-618. doi: 10.1016/j.bbi.2024.10.012
|
| [26] |
Greenstein AE, Hunt HJ. The glucocorticoid receptor modulator relacorilant reverses the immunosuppressive effects of cortisol[J]. Int Immunopharmacol, 2023, 120: 110312. doi: 10.1016/j.intimp.2023.110312
|
| [27] |
于盼, 姜怡, 阙祖俊, 等. 调控固有免疫防治肺癌转移的研究进展[J]. 中国肿瘤临床, 2021, 48(7): 356-360. [Yu P, Jiang Y, Que ZJ, et al. Research progress of regulating innate immunity in prevention and treatment of lung cancer metastasis[J]. Zhongguo Zhong Liu Lin Chuang, 2021, 48(7): 356-360.] doi: 10.3969/j.issn.1000-8179.2021.07.602
Yu P, Jiang Y, Que ZJ, et al. Research progress of regulating innate immunity in prevention and treatment of lung cancer metastasis[J]. Zhongguo Zhong Liu Lin Chuang, 2021, 48(7): 356-360. doi: 10.3969/j.issn.1000-8179.2021.07.602
|
| [28] |
Steel JL, Geller DA, Gamblin TC, et al. Depression, immunity, and survival in patients with hepatobiliary carcinoma[J]. J Clin Oncol, 2007, 25(17): 2397-2405. doi: 10.1200/JCO.2006.06.4592
|
| [29] |
Sivori S, Della Chiesa M, Carlomagno S, et al. Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer[J]. Front Immunol, 2020, 11: 2156. doi: 10.3389/fimmu.2020.02156
|
| [30] |
Capellino S, Claus M, Watzl C. Regulation of natural killer cell activity by glucocorticoids, serotonin, dopamine, and epinephrine[J]. Cell Mol Immun, 2020, 17(7): 705-711. doi: 10.1038/s41423-020-0477-9
|
| [31] |
于盼, 周奕阳, 罗斌, 等. 巨噬细胞在肺癌转移中的作用[J]. 中国肿瘤临床, 2022, 49(6): 299-303. [Yu P, Zhou YY, Luo B, et al. The role of macrophages in metastasis of lung cancer[J]. Zhongguo Zhong Liu Lin Chuang, 2022, 49(6): 299-303.]
Yu P, Zhou YY, Luo B, et al. The role of macrophages in metastasis of lung cancer[J]. Zhongguo Zhong Liu Lin Chuang, 2022, 49(6): 299-303.
|
| [32] |
Yang J, Wei W, Zhang S, et al. Chronic stress influences the macrophage M1-M2 polarization balance through β-adrenergic signaling in hepatoma mice[J]. Int Immunopharmacol, 2024, 138: 112568. doi: 10.1016/j.intimp.2024.112568
|
| [33] |
Sharma A, Vikramdeo KS, Sudan SK, et al. Cortisol affects macrophage polarization by inducing miR-143/145 cluster to reprogram glucose metabolism and by promoting TCA cycle anaplerosis[J]. J Biol Chem, 2024, 300(10): 107753. doi: 10.1016/j.jbc.2024.107753
|
| [34] |
He XY, Gao Y, Ng D, et al. Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment[J]. Cancer cell, 2024, 42(3): 474-486. e12.
|
| [35] |
Pan J, Zhang L, Wang X, et al. Chronic stress induces pulmonary epithelial cells to produce acetylcholine that remodels lung pre-metastatic niche of breast cancer by enhancing NETosis[J]. J Exp Clin Cancer Res, 2023, 42(1): 255. doi: 10.1186/s13046-023-02836-5
|
| [36] |
Cao M, Huang W, Chen Y, et al. Chronic restraint stress promotes the mobilization and recruitment of myeloid-derived suppressor cells through β-adrenergic-activated CXCL5-CXCR2-Erk signaling cascades[J]. Int J Cancer, 2021, 149(2): 460-472. doi: 10.1002/ijc.33552
|
| [37] |
An J, Feng L, Ren J, et al. Chronic stress promotes breast carcinoma metastasis by accumulating myeloid-derived suppressor cells through activating β-adrenergic signaling[J]. Oncoimmunology, 2021, 10(1): 2004659. doi: 10.1080/2162402X.2021.2004659
|
| [38] |
Sommershof A, Scheuermann L, Koerner J, et al. Chronic stress suppresses anti-tumor T(CD8+) responses and tumor regression following cancer immunotherapy in a mouse model of melanoma[J]. Brain Behav Immun, 2017, 65: 140-149. doi: 10.1016/j.bbi.2017.04.021
|
| [39] |
Hu Z, Gu Y, Ye M, et al. Innate immune stimulation prevents chronic stress-induced depressive and anxiogenic-like behaviors in female mice[J]. Int Immunopharmacol, 2022, 111: 109126. doi: 10.1016/j.intimp.2022.109126
|
| [40] |
Lin XH, Liu HH, Hsu SJ, et al. Norepinephrine-stimulated HSCs secrete sFRP1 to promote HCC progression following chronic stress via augmentation of a Wnt16B/β-catenin positive feedback loop[J]. J Exp Clin Cancer Res, 2020, 39(1): 64. doi: 10.1186/s13046-020-01568-0
|
| [41] |
Lu Y, Zhao H, Liu Y, et al. Chronic Stress Activates PlexinA1/VEGFR2-JAK2-STAT3 in Vascular Endothelial Cells to Promote Angiogenesis[J]. Front Oncol, 2021, 11: 709057. doi: 10.3389/fonc.2021.709057
|
| [42] |
Lu J, Zhang X, Su K, et al. Olanzapine suppresses mPFC activity-norepinephrine releasing to alleviate CLOCK-enhanced cancer stemness under chronic stress[J]. Cell Commun Signal, 2024, 22(1): 375. doi: 10.1186/s12964-024-01747-y
|
| [43] |
Zhou S, Ye D, Xia H, et al. Sertraline inhibits stress-induced tumor growth through regulating CD8 + T cell-mediated anti-tumor immunity[J]. Anticancer Drugs, 2022, 33(9): 935-942. doi: 10.1097/CAD.0000000000001383
|
| [44] |
Yang Z, Li Z, Guo Z, et al. Antitumor Effect of Fluoxetine on Chronic Stress-Promoted Lung Cancer Growth via Suppressing Kynurenine Pathway and Enhancing Cellular Immunity[J]. Front Pharmacol, 2021, 12: 685898. doi: 10.3389/fphar.2021.685898
|
| [45] |
Nilsson MB, Le X, Heymach JV. β-Adrenergic Signaling in Lung Cancer: A Potential Role for Beta-Blockers[J]. J Neuroimmune Pharmacol, 2020, 15(1): 27-36. doi: 10.1007/s11481-019-09891-w
|
| [46] |
Haldar R, Ricon-Becker I, Radin A, et al. Perioperative COX2 and β-adrenergic blockade improves biomarkers of tumor metastasis, immunity, and inflammation in colorectal cancer: A randomized controlled trial[J]. Cancer, 2020, 126(17): 3991-4001. doi: 10.1002/cncr.32950
|
| [47] |
De Giorgi V, Grazzini M, Benemei S, et al. Propranolol for Off-label Treatment of Patients With Melanoma: Results From a Cohort Study[J]. JAMA Oncol, 2018, 4(2): e172908. doi: 10.1001/jamaoncol.2017.2908
|
| [48] |
Chang PY, Chung CH, Chang WC, et al. The effect of propranolol on the prognosis of hepatocellular carcinoma: A nationwide population-based study[J]. PLoS One, 2019, 14(5): e0216828. doi: 10.1371/journal.pone.0216828
|
| [49] |
Hiller JG, Cole SW, Crone EM, et al. Preoperative β-Blockade with Propranolol Reduces Biomarkers of Metastasis in Breast Cancer: A Phase Ⅱ Randomized Trial[J]. Clin Cancer Res, 2020, 26(8): 1803-1811. doi: 10.1158/1078-0432.CCR-19-2641
|
| [50] |
Zhao L, Zhu X, Ni Y, et al. Xiaoyaosan, a traditional Chinese medicine, inhibits the chronic restraint stress-induced liver metastasis of colon cancer in vivo[J]. Pharma Biol, 2020, 58(1): 1085-1091.
|
| [51] |
Zheng Y, Zhang J, Huang W, et al. Sini San Inhibits Chronic Psychological Stress-Induced Breast Cancer Stemness by Suppressing Cortisol-Mediated GRP78 Activation[J]. Front Pharmacol, 2021, 12: 714163. doi: 10.3389/fphar.2021.714163
|
| [52] |
Tian X, Wang G, Teng F, et al. Zhi Zi Chi decoction (Gardeniae fructus and semen Sojae Praeparatum) attenuates anxious depression via modulating microbiota-gut-brain axis in corticosterone combined with chronic restraint stress-induced mice[J]. CNS Neurosci Ther, 2024, 30(4): e14519. doi: 10.1111/cns.14519
|
| [53] |
Jiang Y, Hu Y, Yang Y, et al. Tong-Xie-Yao-Fang promotes dendritic cells maturation and retards tumor growth in colorectal cancer mice with chronic restraint stress[J]. J Ethnopharmacol, 2024, 319(Pt 1): 117069.
|
| [54] |
Zhu Y, Chen J, Li J, et al. Ginsenoside Rg1 as a promising adjuvant agent for enhancing the anti-cancer functions of granulocytes inhibited by noradrenaline[J]. Front Immunol, 2023, 14: 1070679. doi: 10.3389/fimmu.2023.1070679
|
| [55] |
Yang Z, Cai W, Chen Y, et al. Jujuboside B Reverse CUMS-Promoted Tumor Progression via Blocking PI3K/Akt and MAPK/ERK and Dephosphorylating CREB Signaling[J]. J Immunol Res, 2022, 2022: 5211368.
|
| [56] |
Hanalis-Miller T, Ricon-Becker I, Sakis N, et al. Peri-operative individually tailored psychological intervention in breast cancer patients improves psychological indices and molecular biomarkers of metastasis in excised tumors[J]. Brain Behav Immun, 2024, 117: 529-540. doi: 10.1016/j.bbi.2024.02.009
|
| [57] |
Zhang S, Yu F, Che A, et al. Neuroendocrine Regulation of Stress-Induced T Cell Dysfunction during Lung Cancer Immunosurveillance via the Kisspeptin/GPR54 Signaling Pathway[J]. Adv Sci (Weinh), 2022, 9(13): e2104132.
|
| [58] |
Qiao G, Chen M, Bucsek MJ, et al. Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response[J]. Front Immunol, 2018, 9: 164. doi: 10.3389/fimmu.2018.00164
|
| [59] |
田建辉, 刘海涛, 董昌盛, 等. 御神在肿瘤防治中的作用探析[J]. 中医杂志, 2018, 59(24): 2093-2098. [Tian JH, Liu HT, Dong CS, et al. Discussion on Defending Spirit in Cancer Prevention and Treatment[J]. Zhong Yi Za Zhi, 2018, 59(24): 2093-2098.]
Tian JH, Liu HT, Dong CS, et al. Discussion on Defending Spirit in Cancer Prevention and Treatment[J]. Zhong Yi Za Zhi, 2018, 59(24): 2093-2098.
|
| [60] |
刘海涛, 田建辉. 调神防治癌症八法[J]. 中华中医药杂志, 2019, 34(5): 2270-2273. [Liu HT, Tian JH. Eight therapies for cancer prevention and treatment by adjusting spirit[J]. Zhonghua Zhong Yi Yao Za Zhi, 2019, 34(5): 2270-2273.]
Liu HT, Tian JH. Eight therapies for cancer prevention and treatment by adjusting spirit[J]. Zhonghua Zhong Yi Yao Za Zhi, 2019, 34(5): 2270-2273.
|
| [61] |
姚嘉良, 刘海涛, 赵外荣, 等. “调神治癌”研究平台的构建[J]. 世界科学技术-中医药现代化, 2023, 25(5): 1525-1532. [Yao JL, Liu HT, Zhao WR, et al. The Construction of a research platform for regulate the mind and treating cancer[J]. Shi Jie Ke Xue Ji Shu-Zhong Yi Yao Xian Dai Hua, 2023, 25(5): 1525-1532.] doi: 10.11842/wst.20210819020
Yao JL, Liu HT, Zhao WR, et al. The Construction of a research platform for regulate the mind and treating cancer[J]. Shi Jie Ke Xue Ji Shu-Zhong Yi Yao Xian Dai Hua, 2023, 25(5): 1525-1532. doi: 10.11842/wst.20210819020
|
| [62] |
刘海涛. 调“神”治疗肺癌的理论、临床与实验研究[D]. 上海中医药大学, 2023. [Liu HT. Clinical and Experimental Research on regulating spirit Treatment of Lung Cancer[D]. Shanghai University of Traditional Chinese Medicine, 2023.]
Liu HT. Clinical and Experimental Research on regulating spirit Treatment of Lung Cancer[D]. Shanghai University of Traditional Chinese Medicine, 2023.
|
| [63] |
姚嘉良, 从恩朝, 李鹤, 等. 形神并调防治妇科恶性肿瘤概述[J]. 世界中医药, 2022, 17(3): 431-436. [Yao JL, Cong EC, Li H, et al. Overview of Prevention and Treatment of Gynecological Cancer by Adjusting Phusiological and Psychological Function[J]. Shi Jie Zhong Yi Yao, 2022, 17(3): 431-436.] doi: 10.3969/j.issn.1673-7202.2022.03.025
Yao JL, Cong EC, Li H, et al. Overview of Prevention and Treatment of Gynecological Cancer by Adjusting Phusiological and Psychological Function[J]. Shi Jie Zhong Yi Yao, 2022, 17(3): 431-436. doi: 10.3969/j.issn.1673-7202.2022.03.025
|
| [64] |
赵外荣, 马子霖, 程天翊, 等. 心肺运动试验在肺癌患者中的应用进展[J]. 中华肿瘤防治杂志, 2023, 30(15): 941-947. [Zhao WR, Ma ZL, Cheng TY, et al. The application of cardiopulmonary exercise test in patients with lung cancer: a review[J]. Zhonghua Zhong Liu Fang Zhi Za Zhi, 2023, 30(15): 941-947.]
Zhao WR, Ma ZL, Cheng TY, et al. The application of cardiopulmonary exercise test in patients with lung cancer: a review[J]. Zhonghua Zhong Liu Fang Zhi Za Zhi, 2023, 30(15): 941-947.
|
| [65] |
田建辉. 传承《黄帝内经》重“神”思想, 倡导“调神治癌”——上海中医药大学附属市中医医院田建辉研究团队“调神治癌”概述[J]. 世界科学技术-中医药现代化, 2023, 25(5): 1517-1524. [Tian JH. Inheriting the idea of "spirit" from the Yellow Emperor's Classic of Internal Medicine, advocating "regulating the spirit to cure cancer"-Tian Jianhui's research team from Shanghai Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Overview of "Regulating the spirit to cure cancer"[J]. Shi Jie Ke Xue Ji Shu-Zhong Yi Yao Xian Dai Hua, 2023, 25(5): 1517-1524.]
Tian JH. Inheriting the idea of "spirit" from the Yellow Emperor's Classic of Internal Medicine, advocating "regulating the spirit to cure cancer"-Tian Jianhui's research team from Shanghai Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Overview of "Regulating the spirit to cure cancer"[J]. Shi Jie Ke Xue Ji Shu-Zhong Yi Yao Xian Dai Hua, 2023, 25(5): 1517-1524.
|
| [1] | WEN Limei, GUO Yali, HOU Qiang, ZHENG Dongxuan, DAI Wu, GAO Xiang, YANG Jianhua, HU Junping. Expression and Clinical Significance of PLCβ4 Gene in Hepatocellular Carcinoma Analyzed Based on TCGA Database and Experimental Validation[J]. Cancer Research on Prevention and Treatment, 2025, 52(6): 502-510. DOI: 10.3971/j.issn.1000-8578.2025.24.1044 |
| [2] | LEI Qingsong, LI Lin. Construction of Prognostic Model for Cuprotosis in Hepatocellular Carcinoma Based on TCGA Database[J]. Cancer Research on Prevention and Treatment, 2023, 50(3): 276-282. DOI: 10.3971/j.issn.1000-8578.2023.22.0875 |
| [3] | WANG Yuxiu, Chen Yu, GONG Daohui, CAO Liuzhao, XU Wenjing, XU Xingxiang, MIN Lingfeng. Evaluation of Expression and Prognostic Significance of FUNDC1 Protein in Non-small Cell Lung Cancer Based on TCGA Database and Clinicopathology[J]. Cancer Research on Prevention and Treatment, 2022, 49(4): 322-327. DOI: 10.3971/j.issn.1000-8578.2022.21.0760 |
| [4] | YANG Tingfang, WANG Li, ZHANG Yong. Expression of FOXO1 in Liver Cancer and Its Prognostic Significance: An Analysis Based on TCGA[J]. Cancer Research on Prevention and Treatment, 2021, 48(8): 774-781. DOI: 10.3971/j.issn.1000-8578.2021.21.0221 |
| [5] | FENG Tingting, CHEN Zhongzhong, YAN Wenjin, WANG Yuxiu, ZHANG Jun, XU Xingxiang, CHEN Yong, YANG Junjun, MIN Lingfeng. Prognosis Analysis of Non-small Cell Lung Cancer with Diameter over 7.0 cm Based on SEER Database[J]. Cancer Research on Prevention and Treatment, 2021, 48(1): 49-54. DOI: 10.3971/j.issn.1000-8578.2021.19.1587 |
| [6] | JIAO Zhaoshuang, ZHANG Huainian. Establishment and Analysis of MicroRNA Prognostic Risk Model of Papillary Thyroid Carcinoma Based on TCGA Database[J]. Cancer Research on Prevention and Treatment, 2020, 47(4): 262-267. DOI: 10.3971/j.issn.1000-8578.2020.19.0947 |
| [7] | PENG Hui, QIN Kai, DAI Yuhong, ZHANG Mengxian, GUO Qiuyun. Establishment of LncRNA Risk Prediction Model for Glioblastoma Based on TCGA Database[J]. Cancer Research on Prevention and Treatment, 2019, 46(5): 417-420. DOI: 10.3971/j.issn.1000-8578.2019.19.0055 |
| [8] | LV Minhao, QIN Li, LI Juntao, GUO Xuhui, LIU Fawen, CUI Shude, ZHANG Hengwei. 原发性乳腺癌分子分型与新辅助化疗疗效及预后的相关性[J]. Cancer Research on Prevention and Treatment, 2015, 42(08): 782-788. DOI: 10.3971/j.issn.1000-8578.2015.08.007 |
| [9] | Jing Jiexian, . Logistic Regression Analysis on Trace Elements and Digestive Tract cancer and Clinical significance[J]. Cancer Research on Prevention and Treatment, 1998, 25(3): 186-188. |
| [10] | Liu Run-xing, . A Logistic Regression Analysis of Risk Factors In Relation to Women Breast Cancer[J]. Cancer Research on Prevention and Treatment, 1994, 21(2): 102-104. |
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: